TGap Ventures

HistoSonics develops a non-invasive tumor ablation system called Edison. This platform uses pulsed sound energy to destroy targeted tissues at the sub-cellular level without requiring incisions or needles.

NeoChord, Inc. is a medical technology company based in St. Louis Park, Minnesota, specializing in innovative solutions for degenerative mitral valve disease (DMR). Founded in 2007, the company has developed the NeoChord Artificial Chordae Delivery System, a proprietary device that enables mitral valve repair to be performed while the heart is still beating. This minimally invasive technique involves a small incision, significantly reducing recovery time and complications compared to traditional procedures that require larger chest incisions and stopping the heart. NeoChord's system addresses severe mitral regurgitation caused by elongated or ruptured chordae tendineae, allowing surgeons to effectively manage blood flow without the need for cardiopulmonary bypass.

Revenew International, LLC, established in 1999 and headquartered in Houston, Texas, specializes in cost recovery and cost containment services. The company assists clients, predominantly Fortune 500 companies across industries like energy and power, in ensuring contractual compliance, recovering lost funds, and enhancing operational efficiency. Revenew's services include contract compliance reviews, supplier payment assessments, and performance improvement strategies. With regional offices across the United States and Canada, Revenew delivers these services through a comprehensive suite of programs tailored to clients' unique needs.

Inspire Medical Systems, Inc. is a medical technology company dedicated to developing and commercializing minimally invasive solutions for patients suffering from obstructive sleep apnea (OSA). Founded in 2007 and headquartered in Golden Valley, Minnesota, the company specializes in innovative implantable neurostimulation technologies. Its primary product, the Inspire system, utilizes a proprietary Upper Airway Stimulation (UAS) therapy that provides a safe and effective treatment for moderate to severe OSA. This technology leverages established principles from cardiac pacing and neurostimulation to deliver mild hypoglossal nerve stimulation, which helps maintain an open airway by continuously monitoring the patient's breathing. Inspire Medical Systems operates primarily in the United States and Europe, generating most of its revenue from the U.S. market.

Revenew International, LLC, established in 1999 and headquartered in Houston, Texas, specializes in cost recovery and cost containment services. The company assists clients, predominantly Fortune 500 companies across industries like energy and power, in ensuring contractual compliance, recovering lost funds, and enhancing operational efficiency. Revenew's services include contract compliance reviews, supplier payment assessments, and performance improvement strategies. With regional offices across the United States and Canada, Revenew delivers these services through a comprehensive suite of programs tailored to clients' unique needs.

Inspire Medical Systems, Inc. is a medical technology company dedicated to developing and commercializing minimally invasive solutions for patients suffering from obstructive sleep apnea (OSA). Founded in 2007 and headquartered in Golden Valley, Minnesota, the company specializes in innovative implantable neurostimulation technologies. Its primary product, the Inspire system, utilizes a proprietary Upper Airway Stimulation (UAS) therapy that provides a safe and effective treatment for moderate to severe OSA. This technology leverages established principles from cardiac pacing and neurostimulation to deliver mild hypoglossal nerve stimulation, which helps maintain an open airway by continuously monitoring the patient's breathing. Inspire Medical Systems operates primarily in the United States and Europe, generating most of its revenue from the U.S. market.

NeoChord, Inc. is a medical technology company based in St. Louis Park, Minnesota, specializing in innovative solutions for degenerative mitral valve disease (DMR). Founded in 2007, the company has developed the NeoChord Artificial Chordae Delivery System, a proprietary device that enables mitral valve repair to be performed while the heart is still beating. This minimally invasive technique involves a small incision, significantly reducing recovery time and complications compared to traditional procedures that require larger chest incisions and stopping the heart. NeoChord's system addresses severe mitral regurgitation caused by elongated or ruptured chordae tendineae, allowing surgeons to effectively manage blood flow without the need for cardiopulmonary bypass.

Regenesis Biomedical Inc. is a medical device company headquartered in Scottsdale, Arizona, specializing in the research, design, manufacture, and sale of noninvasive regenerative medicine products. Founded in 1996, the company is known for its Provant Therapy System, which utilizes an electromagnetic field to reduce pain and swelling associated with surgery and soft tissue injuries. The device serves as an adjunctive treatment option for healthcare providers, catering to various settings, including acute care hospitals, skilled nursing facilities, rehabilitation centers, and home healthcare agencies. Regenesis Biomedical aims to improve the quality of life for patients by offering effective pain management solutions without the use of drugs.

HistoSonics develops a non-invasive tumor ablation system called Edison. This platform uses pulsed sound energy to destroy targeted tissues at the sub-cellular level without requiring incisions or needles.

ValenTx, Inc. is a medical device company based in Maple Grove, Minnesota, that specializes in developing innovative therapy solutions for patients suffering from obesity and obesity-related metabolic disorders. Founded in 2002, ValenTx focuses on minimally-invasive treatment methods, including an endoluminal bypass therapy that replicates the anatomical changes of the traditional Roux-en-Y gastric bypass procedure. This technology features an adjustable, removable, and replaceable device designed to address conditions such as type-2 diabetes and hypertension, aiming to improve patient outcomes in the management of these chronic health issues.

Small Bone Innovations (SBi) is a medical device company specializing in the design, manufacture, and distribution of implants tailored for small bones and joints. Their product portfolio focuses on trauma and arthroplasty applications, catering specifically to the thumb, hand, wrist, elbow, foot, and ankle regions. SBi's offerings include basal joint arthritis treatments and implants designed to replace anatomic joint surfaces while preserving bones and minimizing disruption to collateral ligaments and soft tissues.

InStadium is a company specializing in live sports fan engagement, focusing on connecting brands with fans at live events. It operates across more than 425 professional and collegiate stadiums and arenas nationwide, providing multi-channel brand engagement opportunities for Fortune 500 clients. Through its platform, InStadium offers in-venue advertising services and promotional marketing campaigns, enabling brands to reach millions of captive consumers during tens of thousands of events annually. The company's extensive venue network allows for year-round access to multiple markets, offering flexibility for integrated media campaigns tailored to specific drive periods and media schedules.

MinuteClinic is a provider of retail-based healthcare services that focuses on delivering affordable and convenient medical care both in person and virtually. The clinic offers a wide range of primary care-enabled services, including treatments for common ailments such as allergies, bladder infections, bronchitis, ear infections, pink eye, styes, sinus infections, strep throat, and swimmer's ear. By enabling users to access healthcare services easily and at a low cost, MinuteClinic aims to enhance the overall healthcare experience for its patients.